Download PDF
CC BY 4.0 · Indian J Med Paediatr Oncol
DOI: 10.1055/s-0044-1788311
Original Article

Real-World Evidence Data on Adverse Reactions to Infusion of Thawed Hematopoietic Progenitor Cells: Retrospective Analysis from a Single Center in India

Aseem K. Tiwari
1   Department of Transfusion Medicine, Medanta—The Medicity, Gurgaon, Haryana, India
,
Geet Aggarwal
1   Department of Transfusion Medicine, Medanta—The Medicity, Gurgaon, Haryana, India
,
Swati Pabbi
2   Department of Transfusion Medicine, Amrita Institute of Medical Sciences, Faridabad, Haryana, India
,
Samruddhi Pawar
1   Department of Transfusion Medicine, Medanta—The Medicity, Gurgaon, Haryana, India
,
Ganesh Rawat
1   Department of Transfusion Medicine, Medanta—The Medicity, Gurgaon, Haryana, India
,
Sunil Golia
1   Department of Transfusion Medicine, Medanta—The Medicity, Gurgaon, Haryana, India
,
Shubham Gupta
1   Department of Transfusion Medicine, Medanta—The Medicity, Gurgaon, Haryana, India
,
Nitin Sood
3   Department of Hematology and Stem Cell Transplant, Medanta—The Medicity, Gurgaon, Haryana, India
,
Satya Prakash Yadav
4   Department of Paediatric Hemato-oncology, Medanta—The Medicity, Gurgaon, Haryana, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Introduction Adverse reactions (ARs) occur during infusion of thawed hematopoietic progenitor cells (HPCs) either due to infusion or its contents. There is sparse literature on it in the world and none in India. Therefore, we retrospectively analyzed ARs occurring during and within 1 hour of infusion of thawed HPCs.

Materials and Methods This study was done in a tertiary-care center, between 2019 and 2022. Data collected included age, gender, diagnosis, specifications of contents of infusion product (volume of product, volume of dimethyl sulfoxide per kg body weight, total nucleated cell count per microliter, and viability of CD 34+ cells), pretreatment given, and ARs, if any from the procedure records and the hospital information system.

Results The present study included 55 transplant patients, and the commonest diagnosis was Hodgkin lymphoma. All were prophylactically hydrated and premedicated as per institutional protocol. AR was seen in 56.36% (n = 31); the commonest type of ARs was nausea (n = 26) followed by vomiting (n = 13), abdominal pain (n = 4), shivering (n = 3), transient tachycardia (n = 2), transient hypotension (n = 2), and hematuria (n = 1). All ARs were managed clinically by giving symptomatic treatment. No patients required intensive care, and there were no deaths or aborted procedures. Characteristics of infusion products had no significant correlation to ARs.

Discussion To the best of the author's knowledge, this is the first such study from India. We report an overall incidence of ARs of 56.36%, which is similar to the previously published data on ARs during thawed HPC infusions. AR is a common occurrence and can be managed medically and symptomatically.

Keywords

adverse reactions - infusion - transplant - hematopoietic progenitor cell

Note

The manuscript has been read and approved by all the authors and the requirements for authorship have been met. Each author believes that the manuscript represents honest work.


Patient Consent

Informed consent was obtained from each patient before commencing treatment. Patient identifiers were removed and complete confidentiality was maintained. There was no study-specific consent since anonymised data was used for this observational analysis. Institutional review board (IRB) gave a waiver for study-specific consent.


Ethical Approval

The study has been approved by the Institutional Ethics Committee on 29.03.2023, Reference no: 1513/2023 (Academic). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.


Authors Contribution

A.K.T. conceptualized and designed the study protocol, screened eligible studies previously published and analyzed the data. G.A. and S. Pabbi contributed to writing the report, analyzing data, and interpreting the results. S. Pawar, S. Golia, and S. Gupta contributed to extracting data from the procedure sheet and HIS, writing the report, and updating the reference lists. G.R. provided technical support during the conduct of the study. N.S. and S.Y. contributed to manuscript editing and review. All authors reviewed and approved the final manuscript.




Publication History

Article published online:
22 July 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Simon TL, McCullough J, Snyder EL. et al, eds. Rossi's Principles of Transfusion Medicine. 6th ed.. Hoboken, NJ: John Wiley & Sons Ltd; 2022: 617-623
    CrossrefSearch in Google Scholar
  • 2 Connelly-Smith LS, Linenberger ML. eds. The collection and processing of hematopoietic progenitor cells. In: AABB Technical Manual. 20th ed.. MD: American Association of Blood Banks; 2020: 737-758
    Search in Google Scholar
  • 3 Pamphilon D, Mijovic A. Storage of hemopoietic stem cells. Asian J Transfus Sci 2007; 1 (02) 71-76
    CrossrefPubMedSearch in Google Scholar
  • 4 Wingard JR, Gastineau DA, Leather HL. et al, eds. Hematopoietic Stem Cell Transplantation: A Handbook for Clinicians, 2nd ed. Bethesda, MD: AABB; 2015: 228-231
    Search in Google Scholar
  • 5 Truong TH, Moorjani R, Dewey D, Guilcher GM, Prokopishyn NL, Lewis VA. Adverse reactions during stem cell infusion in children treated with autologous and allogeneic stem cell transplantation. Bone Marrow Transplant 2016; 51 (05) 680-686
    CrossrefPubMedSearch in Google Scholar
  • 6 Lecchi L, Giovanelli S, Gagliardi B, Pezzali I, Ratti I, Marconi M. An update on methods for cryopreservation and thawing of hemopoietic stem cells. Transfus Apheresis Sci 2016; 54 (03) 324-336
    CrossrefPubMedSearch in Google Scholar
  • 7 Bakken AM. Cryopreserving human peripheral blood progenitor cells. Curr Stem Cell Res Ther 2006; 1 (01) 47-54
    CrossrefPubMedSearch in Google Scholar
  • 8 Vidula N, Villa M, Helenowski IB. et al. Adverse events during hematopoietic stem cell infusion: analysis of the infusion product. Clin Lymphoma Myeloma Leuk 2015; 15 (11) e157-e162
    CrossrefPubMedSearch in Google Scholar
  • 9 Devadas SK, Khairnar M, Hiregoudar SS. et al. Is long term storage of cryopreserved stem cells for hematopoietic stem cell transplantation a worthwhile exercise in developing countries?. Blood Res 2017; 52 (04) 307-310
    CrossrefPubMedSearch in Google Scholar
  • 10 Mukhopadhyay A, Gupta P, Basak J. et al. Stem cell transplant: an experience from eastern India. Indian J Med Paediatr Oncol 2012; 33 (04) 203-209
    Thieme ConnectPubMedSearch in Google Scholar
  • 11 Jain R, Hans R, Totadri S. et al. Autologous stem cell transplant for high-risk neuroblastoma: achieving cure with low-cost adaptations. Pediatr Blood Cancer 2020; 67 (06) e28273
    CrossrefPubMedSearch in Google Scholar
  • 12 Setia RD, Arora S, Handoo A. et al. Outcome of 51 autologous peripheral blood stem cell transplants after uncontrolled-rate freezing (“dump freezing”) using -80°C mechanical freezer. Asian J Transfus Sci 2018; 12 (02) 117-122
    CrossrefPubMedSearch in Google Scholar
  • 13 Cordoba R, Arrieta R, Kerguelen A, Hernandez-Navarro F. The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product. Bone Marrow Transplant 2007; 40 (11) 1063-1067
    CrossrefPubMedSearch in Google Scholar
  • 14 Otrock ZK, Sempek DS, Carey S, Grossman BJ. Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single-center observational study. Transfusion 2017; 57 (06) 1522-1526
    CrossrefPubMedSearch in Google Scholar
  • 15 Gokarn A, Tembhare PR, Syed H. et al. Long-term cryopreservation of peripheral blood stem cell harvest using low concentration (4.35%) dimethyl sulfoxide with methyl cellulose and uncontrolled rate freezing at -80 °C: an effective option in resource-limited settings. Transplant Cell Ther 2023; 29 (12) 777.e1-777.e8
    CrossrefPubMedSearch in Google Scholar
  • 16 Solves P, Penalver M, Arnau MJ. et al. Adverse events after infusion of cryopreserved and non cryopreserved hematopoietic progenitor cells from different sources. Ann Stem Cell Res Ther. 2018; 1 (01) 1004
    Search in Google Scholar
  • 17 Martín-Henao GA, Resano PM, Villegas JM. et al. Adverse reactions during transfusion of thawed haematopoietic progenitor cells from apheresis are closely related to the number of granulocyte cells in the leukapheresis product. Vox Sang 2010; 99 (03) 267-273
    CrossrefPubMedSearch in Google Scholar